Skip to main content

Table 5 Actual AFP concentration in patients with high AFP levels

From: Alpha-fetoprotein predicts the treatment efficacy of immune checkpoint inhibitors for gastric cancer patients

No.

AFP concentration(ng/ml)

PFS (months)

OS (months)

1

≥ 1210.00

2.77

12.37

2

21.58

1.97

3.27

3

140.40

2.33

10.90

4

406.30

1.70

2.40

5

84.05

2.90

11.53

6

≥ 1210.00

1.37

2.20

7

96.70

14.30

14.30

8

1207.00

5.57

8.53

9

31.16

1.73

15.90

10

26.03

2.87

8.40

11

30.00

7.80

24.10

12

21.00

27.47

27.47

13

234.00

3.93

10.80

14

≥ 1210.00

1.97

3.03

15

528.00

5.10

6.47

16

1192.00

7.10

7.10

17

≥ 1210.00

4.43

25.03

18

29.05

4.33

8.40

19

≥ 1210.00

4.50

4.50

20

28.45

5.87

5.87

  1. AFP: alpha-fetoprotein